Just a few days ago, I shared an update on my views around psychedelics—both as a mental health tool and as a speculative investment theme.
At the start of the year, I highlighted psychedelics as a space where science, sentiment, and politics might finally align to legitimize an industry long stuck on the fringes.
I pointed to three names from my 25 Stocks To Watch for 2025 as particularly interesting that I would watch for the year.


